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We introduce two novel methods for multivariate genome-wide association meta-analysis 
(GWAMA) of related traits that correct for sample overlap. A broad range of simulation scenarios 
supports the added value of our multivariate methods relative to univariate GWAMA. We applied 
the novel methods to life satisfaction, positive affect, neuroticism, and depressive symptoms, 
collectively referred to as the well-being spectrum (Nobs = 2,370,390), and found 304 significant 
independent signals. Our multivariate approaches resulted in a 26% increase in the number of 
independent signals relative to the four univariate GWAMA, and in a ~ 57% increase in the 
predictive power of polygenic risk scores. Supporting transcriptome -and methylome-wide analyses 
(TWAS/MWAS) uncovered an additional 17 and 75 independent loci, respectively. Bioinformatic 
analyses, based on gene expression in brain tissues and cells, showed that genes differentially 
expressed in the subiculum and GABAergic interneurons are enriched in their effect on the well-
being spectrum. 
In the past decade, genome-wide association studies (GWAS) have provided insights into the genetic basis 
of quantitative variation in complex traits
1
. With summary statistics of these GWASs becoming public and 
the development of linkage disequilibrium score regression (LDSC)2,3, genetic correlations between traits 
can be systematically estimated (e.g. Brainstorm consortium4). Levering this widely observed genetic 
overlap between traits, we introduce two novel methods for multivariate genome-wide association meta-
analysis, where we define a multivariate model as a model where the effect of a single SNP is considered 
for multiple traits: 1) N-weighted multivariate GWAMA (N-GWAMA), with a unitary effect of the SNP 
on all traits, and 2) model averaging GWAMA (MA-GWAMA), where we relaxed the assumption of a 
unitary effect of the SNP on all traits. Both methods are well equipped to deal with (unknown) sample 
overlap. The dependence between effect sizes (error correlation) induced by possible sample overlap is 
estimated from the univariate GWAMA using LDSC2,3. Furthermore, the univariate LDSC intercept is 
used to correct for population stratification and cryptic relatedness. Both methods have advantages over 
existing methods. In contrast to MultiPhen5, CCA (mv-PLINK)6, Combined-PC7, and mv-BIMBAM8, 
both our methods can be applied without the need of individual-level genotypic data as only 
GWAS/GWAMA summary-statistics are required. Additionally, in contrast to SHom
9, N -and MA-GWAMA 
take a more precise estimate of the error correlation into account. In contrast to MTAG10, MA-GWAMA , 
similar to SHet
9, generates trait specific estimates for each SNP allowing for a certain degree of 
heterogeneity (see online methods). Finally, in contrast to TATES11, both N-GWAMA and MA-GWAMA 
generate effect sizes for the multivariate effect where TATES only generates a P-value. The absence of a 
signed statistic in TATES complicates or even prohibits polygenic prediction.  
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Results 
Simulations 
We performed simulations to elucidate in which scenarios N-GWAMA and MA-GWAMA outperform 
univariate GWAMA, and when N-GWAMA outperforms MA-GWAMA, or the reverse. GWAMA 
summary statistics were simulated for a range of different scenarios. For each scenario we simulated four 
heritable traits (h2SNP = 30%), and varied the genetic correlation between the four traits from .1 to .9 (see 
online methods). We sampled 80,000 causal SNPs for 80,000 individuals from the UK Biobank12. For 
each trait, 40,000 individuals were simulated, and the sample overlap between the traits ranged from 0 to 
25,000 individuals. On the generated data, four univariate GWAMAs were performed. We chose 
parameters that far exceed the reported h2SNP for many complex traits, which allows us to simulate at 
smaller sample sizes (N =80,000), reducing the computational burden.  
We found that in the presence of genetic correlations equal to, or higher than, .5, both N-GWAMA and 
MA-GWAMA outperform univariate GWAMA (Supplementary Fig. 1 and Supplementary Table 1). 
The added value of multivariate analysis disappears when traits showed lower genetic correlations (≤ 0.4). 
We performed another four simulation scenarios in which we varied the SNP heritability together with the 
sample size. We kept the product of the h2SNP and the sample size constant in order to consider a realistic 
SNP heritability, which implies that the expectation of the z-statistic remains constant (see online 
methods). We simulated data with h2SNP of 40% (N=30,000), 20% (N=60,000), and 10% (N=120,000), 
where we kept the genetic correlations between traits constant (at rg = 0.7). Finally, we simulated four 
traits with a genetic correlation of 0.7 (N=40,000), without sample overlap. In all scenarios, both 
multivariate methods outperformed univariate GWAMA (Supplementary Table 1). To validate MA-
GWAMA, we simulated data where the assumption of a unitary effects of the SNP on all traits was relaxed 
(see online methods). We found that, in the scenario where a SNP has an effect on at least three out of four 
traits, N-GWAMA and MA-GWAMA perform equally well. However, when a SNP has an effect on two 
out of four traits or one out of four traits, MA-GWAMA outperforms N-GWAMA (Supplementary Table 
2). Note that in scenarios where SNPs influence fewer than half of the traits under consideration, 
univariate methods, such as, GWAMA can outperform multivariate N- and MA-GWAMA. 
Application to the well-being spectrum 
Following our longstanding research interest13–16, we applied our methods to the following traits; life 
satisfaction (LS), positive affect (PA), neuroticism (NEU), and depressive symptoms (DS). Despite the 
fact that the high phenotypic and genetic correlations between these traits is strongly suggestive of a 
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common underlying biology, most research is still characterized by separate analyses. Acknowledging 
this, we performed both N-GWAMA and MA-GWAMA (Nobs= 2,370,390, Supplementary Table 3) of 
these four traits to increase the power to identify associated genetic variants.  
Our analyses leverage published univariate GWAMAs of life satisfaction15,17 (Nobs = 80,852; 2 studies), 
positive affect12,15,17 (Nobs = 410,603; 3 studies), neuroticism
12,15,17,18 (Nobs = 582,989; 6 studies), and 
depressive symptoms12,15,17,19,20 (Nobs = 1,295,946; 10 studies). Overall, the mean genetic correlations 
between different measures of the same trait were higher (LS, rg = 0.68, PA, rg = 0.9, NEU, rg = 0.84, and 
DS, rg = 0.89) than the mean genetic correlation between measures of different traits (rg = 0.7; Fig. 1 
(upper triangle)). This justifies our two-stage approach of first meta-analyzing the datasets measuring the 
same traits (LS, PA, NEU, and DS) and secondly meta-analyzing the four resulting datasets into what we 
refer to as the well-being spectrum (Nobs = 2,370,390; Supplementary Fig. 2). For the purpose of the 
multivariate GWAMA, we reversed the estimated SNP effects on neuroticism and depressive symptoms to 
ensure a positive correlation with life satisfaction and positive affect. The dependence between effect sizes 
(error correlation) induced by sample overlap was estimated from the genome-wide summary statistics 
obtained from the univariate GWAMA analyses using LDSC2,3 (see online methods and Fig. 1 (lower 
triangle)). Knowledge of the error correlation between univariate meta-analyses allowed dependent 
samples to be meta-analyzed, providing a gain in power while guarding against inflated type-1 error rates 
(see online methods).  
Multivariate GWAMA results 
In our N-GWAMA, we identified 231 independent (250kb window LD > 0.1) loci associated with the 
well-being spectrum (Fig. 2A, Supplementary Table 4), whereas MA-GWAMA identified 148 (LS), 191 
(PA), 263 (NEU), and 239 (DS) loci (Fig. 2B-E), some of which overlap, resulting in 289 independent 
signals (Supplementary Table 4 -8). The overlap in genome-wide significant loci divided by the 
geometric mean of the number of loci discovered for the traits is highly consistent with the genetic 
correlation between the traits (Supplementary Table 9). Of these 289 independent MA-GWAMA signals, 
181 were within a 50kb window of the independent signals present in the N-GWAMA analysis (78.3%). 
Considering both multivariate methods, we found 304 independent genome-wide signals associated with 
the well-being spectrum. This is a 26% increase in comparison to the independent signals found in the 
univariate GWAMAs (LS, PA, NEU, and DS, Supplementary Table 10 and Supplementary Fig. 3A-D). 
The low LD-score intercepts for all analyses confirmed that the inflation in test statistics was due to an 
increase in signal, rather than population stratification or inaccurate accounting for sample overlap (see 
online methods, Supplementary Table 11).  
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We performed a lookup for the genome-wide significant loci reported in published studies of related traits. 
We identified 26 loci in close proximity (< 250 kb) to the 44 genome wide significant loci (59.1%) 
reported for major depressive disorder (MDD)21. In addition, we identified 58 loci in close proximity to 
the 79 loci identified using an alternative multivariate method considering well-being spectrum traits 
(73.4%)10. Using height as a negative control (rg ~ .05 with our included traits), we identified 37 loci in 
close proximity to the 697 loci associated with height (5.3%)22.  
Polygenic prediction 
We compared the predictive power of polygenic scores constructed from univariate GWAMA against N-
GWAMA and MA-GWAMA. Prediction of measures of LS, PA, NEU, and DS was performed in samples 
of the Netherlands Twin Register (NTR: meanN = > 8,100) and Understanding Society (US: meanN > 8,846) 
17,23. We evaluated the predictive power of each polygenic score by its incremental R2 value, defined as the 
increase in R2 of the regression including the polygenic score as independent variable together with a set 
of controls (age, age2, sex, and ten principal components) over a regression omitting the polygenic score. 
Univariate GWAMA polygenic scores had an incremental R2 value of 0.13% for LS, 0.49% for PA, 1.53% 
for NEU, and 1.22% for DS. The corresponding N-GWAMA and MA-GWAMA had larger incremental R2 
(for LS: 0.94% and 0.92%, for PA: 1.10% and 1.06%, for NEU: 1.68% and 1.61%, and for DS: 1.64% and 
1.63%). On average, N-GWAMA improved prediction by 59% and MA-GWAMA improved prediction by 
55% (Supplementary Fig 4 and Supplementary Table 12). 
Bioinformatics 
Given the equal performance of both multivariate GWAMAs, and the assumption of TWAS, MWAS, and 
LDSC that the test statistics follow a standard normal distribution under the null hypothesis of no effect, 
we have chosen to perform the bioinformatics analyses with the N-GWAMA results. 
Transcriptome -and Methylome-wide Analyses 
Multivariate GWAMA aggregates the effect of a single SNP across multiple traits, informed by prior 
knowledge of the genetic correlation between these traits. Next, we aggregated the effect across multiple 
SNPs based on prior knowledge that some of these SNPs influence the expression level of a gene 
transcript or the methylation level at a CpG site (mQTL) measured in whole blood. These methods 
(known as TWAS/MWAS) enable identification of genes involved in complex traits 24–26. In TWAS, we 
uncovered 97 transcript-trait associations (45 loci) significant at a Bonferroni corrected significance level 
(p < 5.2 x 10-6). For 17 TWAS hits (14 loci), the corresponding locus (1000 kb around the transcript) did 
not contain a significant N-GWAMA SNP. For 49 out of the 97 transcripts (30 loci), the maximum LD 
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between the TWAS model SNPs and N-GWAMA top SNP in the corresponding locus was larger than 0.8 
(Supplementary Table 13). Furthermore, we found 913 CpG methylation-trait associations mapping to 
141 loci at a Bonferroni corrected significance level. For 75 out of 913 CpG methylation-trait associations 
(36 loci), the corresponding locus did not contain a N-GWAMA significant signal. For 396 CpG 
methylation-trait associations (83 loci), the maximum LD between the MWAS model SNPs and a N-
GWAMA top SNP was larger than 0.8 (Supplementary Table 14).  
A locus of particular interest was found within the major histocompatibility complex. Recent work has 
identified 3 individual signals related to schizophrenia (SCZ) in the MHC region, one of which is linked to 
complement 4 (C4A) gene expression and synapse elimination during puberty27. The genome-wide 
significant signal for the well-being spectrum in the MHC region is not in strong LD with lead eQTL’s for 
C4A gene expression. Rather, a second independent signal tagged by rs13194504 is associated with both 
schizophrenia and well-being. TWAS results for the MHC region implicate the expression of ZKSCAN4 in 
the etiology of well-being (Supplementary Fig. 5). 
Stratified LD Score Regression 
We performed further biological annotation using stratified LD score regression2,3. Our first analysis 
aimed to confirm the involvement of the central nervous system (CNS) in the etiology of the well-being 
spectrum. Our second analysis aimed to pinpoint specific locations in the brain. Our final analysis used 
single cell sequencing data to identify specific cell type involvement.  
We considered the enrichment in the N-GWAMA derived SNP set of 220 genomic annotations (33 brain 
and 187 non-brain annotations), which reflected the locations of four specific histone marks (H3K4me1, 
H3K4me3, H3K27ac, or H3K9ac) in 54 tissues in their effect on the well-being spectrum28. This allows 
detection of, for example, enrichment of regions of the genome which are histone modified in the 
prefrontal cortex. Such enrichment would suggest the involvement of processes in the prefrontal cortex in 
the etiology of the well-being spectrum. Our analyses revealed significant enrichment of 69 annotations 
characterized by 32 histone marks in 10 brain tissues (Supplementary Table 15 and Supplementary 
Figure 6). Note that the top 15 significant annotations involve brain tissues. Among these brain tissues are 
the mid-frontal and inferior-temporal lobe, fetal brain, cingulate and angular gyrus, germinal matrix, 
hippocampus anterior caudate, substantia nigra, and the neurosphere.  
In order to more accurately pinpoint brain regions where genes relevant to the well-being spectrum are 
differentially expressed, we computed stratified LD scores based on differential gene expression in an 
anatomically comprehensive set of 210 brain regions, based on 3707 measurements in 6 human brains29. 
   
7 
 
For each brain region, genes were selected that showed higher expression compared to all other regions 
(global differential gene expression). The LD scores were significantly enriched at FDR < 0.05 at multiple 
gyri in the cortex (Supplementary Table 16). Differential gene expression appeared driven mainly by 
transcriptional differences between gross anatomical structures in the brain (cortex, sub-cortical structures, 
brainstem, and cerebellum). To reveal regions related to the well-being spectrum within these structures, 
we divided the 210 regions into four sets (brain stem, cortex, sub cortex, and cerebellum) based on their 
locations and computed differential gene expression across the regions within each structure (local 
differential gene expression).  
Our results showed a significant (Bonferroni corrected) enrichment of N-GWAMA signal for genes 
specifically expressed in the subiculum (Z = 3.47, p < 0.001; Fig. 3A-C and Supplementary Table 17-
20). The subiculum is considered part of the hippocampal formation and plays a key role in hippocampal-
cortical interaction30, in the inhibition of the Hypothalamic-Pituitary-Adrenal-axis and the human response 
to stress31. We repeated the analyses using GWAMA summary statistics of educational attainment (EA)32 
and schizophrenia33, two traits that are relatively weakly genetically correlated with the well-being 
spectrum (rg = -0.15, p = 1.81 x 10
-10, and rg = 0.34, p = 2.54 x 10
-64), but for which the brain has been 
implicated in their etiologies. In particular, we wanted to see whether the signal observed in the subiculum 
was specific to the well-being spectrum. As a negative control, we considered the enrichment of genes 
differentially expressed in all brain regions on height22. We found no enrichment of genes differentially 
expressed in the subiculum on EA (Z=1.251; p = 0.105), but found an effect on SCZ (Z = 2.938; p = 
0.002). No region was significantly enriched in their effect on height (p > 0.05). All results of the 
differential gene expression analysis were mapped to the MNI coordinates at which the tissue samples 
were obtained, allowing future integration of our findings and other neuroimaging modalities 
(Supplementary Table 21 and Fig. 3A-C).  
Finally, we obtained the publicly available matrix of gene counts generated based on single nuclei (N = 
14,963) from the prefrontal cortex and hippocampus of multiple human donors by Habib et al (2017)34. 
We divided these nuclei into 7 types of neurons, 2 subtypes of astrocytes, oligodendrocytes, 
oligodendrocyte precursors cells, microglia, endothelial cells, and unclassified cells (hippocampus and 
prefrontal cortex), and computed cell type specific genes for the different types of neurons (see online 
methods). Using LDSC we tested the enrichment of all cell-types in the N-GWAMA. Significant 
enrichment was observed for GABAergic interneurons sampled from the hippocampus and prefrontal 
cortex (GABA1; Z = 3.42; p = 3.64 x 10
-6 and GABA2 Z = 3.7; p = 6.54 x 10
-7; Supplementary Table 22 
and Fig 3D).  
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Discussion 
We have introduced N-GWAMA and MA-GWAMA, two novel methods for conducting multivariate of 
GWAMA summary statistics of related traits. While previous univariate analyses of traits in the well-being 
spectrum have been moderately successful, we gained power by the use of multivariate analyses. N-
GWAMA and MA-GWAMA identified 304 loci associated with some, but not all, traits in the well-being 
spectrum, and provided flexibility in terms of model specification. Note that model averaging can be 
extended to incorporate other multivariate models such as MTAG10, or models specified in Genomic 
SEM35. Model averaging can in fact incorporate any multivariate GWAMA or GWAS model for which the 
per SNP model fit can be expressed in terms of an AICc fit statistic. Both N-GWAMA and MA-GWAMA 
are complementary of each other and can thus be used together to identify genetic variants associated with 
clusters of genetically correlated traits. We illustrate the power gain in multivariate GWAMA over 
univariate GWAMA for traits genetically correlated above 0.4 using simulations. Empirical application 
showed that polygenic scores based on multivariate GWAMA outperform polygenic scores based on 
univariate GWAMA. Besides the advantages of the novel methods, it should be noted that both techniques 
estimate the error covariance between test statistics from LDSC and therefore inherit the assumptions 
from LDSC. This implies, that all limitations which apply to LDSC do also apply to our methods. For 
instance, a previous study found, through simulations, that the univariate LDSC intercept can be biased at 
very large sample sizes coupled with a high (SNP) heritability36.  
We used TWAS and MWAS to identify additional loci related to variation in complex traits, like well-
being, by aggregating the effects across multiple SNPs based on prior knowledge that some of these SNPs 
influence the expression level of a gene transcript or the methylation level at a CpG site. By leveraging the 
N-GWAMA results, LD score regression, and an atlas of brain gene expression, we were able to pinpoint 
brain regions where region specific gene-expression exists for genes enriched in their effect on well-being. 
We report evidence for enrichment of genes differentially expressed in the subiculum. Furthermore, we 
find enrichment for GABAergic interneurons. In the regions for which we have cell types available 
(hippocampus and prefrontal cortex), we find cell type specific enrichment for the well-being spectrum. 
However, it stands to reason that the same cell type specific enrichment in other regions may exist, which 
we may have missed. Gene expression is known to vary systematically between cell-types within the 
brain37 (e.g neurons, microglia, astrocytes) and developmental phases38 (prenatally, childhood, adulthood 
and old age), and likely even between sub-types of a single cell type. Differences in gene expression 
across or within cell types may induce differences between regions as cell type composition might differ 
between regions. This limitation needs to be addressed in future well-being research, capitalizing on 
ongoing efforts to categorize gene expression across the human brain at increased (single cell) resolution. 
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Single cell sequencing (e.g. drop-seq based anatomically comprehensive survey of the brain), based on 
donors deceased at different ages, could disentangle cell-type-specific from region-specific differential 
gene expression, as well as age specific gene expression39. The results of our new multivariate GWAMA 
methods can be meaningfully mapped to brain regions based on a coordinate system used within multiple 
other neuroscientific disciplines, facilitating future integration of genetic and neuroscientific research on 
the well-being spectrum.  
 
  
   
10 
 
URLs 
N-GWAMA and MA-GWAMA software is available at: https://github.com/ 
baselmans/multivariate_GWAMA/ 
TWAS and MWAS software is available at http://bbmri.researchlumc.nl/atlas/#data;  
BIOS consortium https://www.bbmri.nl/acquisition-use-analyze/bios/  
TWAS and MWAS prediction models http://bbmri.researchlumc.nl/atlas/#data  
Brain Map gene expression brain regions http://www.brain-map.org/ 
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Figure Legends 
Fig 1: Genetic correlations and error correlations (cross-trait intercepts) between the included 
GWAMA data sets. Upper triangle: genetic correlations. Lower triangle: error correlation representing 
the magnitude of inflation due to population stratification. Red boxes indicate trait-specific genetic 
correlations and error correlation. Note, UKB1 represents Caucasian UK Biobank participants living in 
the UK. UKB2 represents Caucasian UK Biobank participants living in the UK that are relatives from 
UKB1, and UKB3 represents Caucasian UK Biobank participants not living in the UKB. Sample size of 
the included traits are displayed in Supplementary Table 3. Note that estimates of  genetic correlations as 
estimated in LDSC  are not bounded at 1. 
 
Fig. 2. Manhattan plots of N-weighted and model averaging GWAMA. (a) N-weighted GWAMA. 
Model averaging GWAMA of (b) life satisfaction, (c) positive affect, (d) neuroticism, (e) depressive 
symptoms. All plots in all panels are based on the same set of SNPs. The x-axis represents the 
chromosomal position, and the y-axis represents the significance on a –log10 scale. Sample size of the 
included traits are displayed in Supplementary Table 3. Each approximately independent genome-wide 
significant association (“lead SNP”) is marked by Δ (p < 5 X 10-8). 
 
Fig. 3 Local differential gene expression between subcortical structures and enrichment of 
individual cell-type enrichment. Local differential gene expression between subcortical structures 
identifies enrichment of genes specifically expressed in the subiculum (Z = 3.47, p < 0.001), in their effect 
on the well-being spectrum. (a) coronial view (b) sagittal view (c) axial view. The location of the samples 
of brain tissues which were used to measure gene expression by Hawrylycz et al. (2012) is projected to a 
standard MNI template brain (“Colin27”). The figure is centered on the averaged MNI coordinates of 
brain samples which are part of the annotation “left Subiculum” (x = 77, y = 90 and z = 60).(d) bar graph 
representing the cell-type specific enrichment of GABAergic neurons (GABA1; Z = 3.42; p = 3.64X10
-6 
and GABA2 Z = 3.7; p = 6.54X10
-7; tested one-sided). Dotted line indicate significant at the FDR < 0.01 
level, dashed line indicate significance at the FDR < 0.05 level. GABA = GABAergic interneurons, exPFC 
= glutamatergic neurons from the prefrontal cortex, exCA1/3 = pyramidal neurons from the hippocampus 
CA region, exDG = granule neurons from the hip denate gyrus, OPC = oligodendrocyte precursors cells, 
ASC = astrocytes, NSC, neural stem, cells, MG = microglia, ODC1 = oligodendrocytes, endothelian = 
endothelian cells. N-GWAMA results were used for all analyses (Nobs = 2,370,390). 
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Online Methods 
N-weighted GWAMA (N-GWAMA)  
We obtained summary statistics from univariate GWAMAs of life satisfaction, positive affect, neuroticism, 
and depressive symptoms 12,15,17–20. We used the tool DIST40 to impute HapMap2 summary statistics to the 
1000Genomes Phase1 reference. To quantify the dependence between the univariate GWAMAs, we 
estimated the cross trait LD score intercept (CTI)2,3: 
 
𝐶𝑇𝐼 =  
𝑁𝑠 ∗ 𝑟𝑝
√𝑁1𝑁2
 
 
Where Ns equals the sample overlap, N1 the sample size for trait 1, N2 the sample size for trait 2, and 𝑟𝑝 
the phenotypic correlation between trait one and two. The CTI is approximately equal to the covariance 
between the test statistics obtained in univariate GWAMAs of trait 1 and 2. We assume that the estimated 
CTI is equal to the true CTI, though note the uncertainty in the estimated CTI is generally low. Given the 
estimated covariance between effect sizes, we can meta-analyse the four dependent GWAMAs and obtain 
a multivariate test statistic per SNP k: 
Ζ𝑘 =  
∑ (𝑤𝑖𝑘 ∗ 𝑍𝑖𝑘)
4
𝑖=1
√∑ (𝑤𝑖𝑘 ∗ 𝑉𝑖)
4
𝑖=1 + ∑ ∑ (√𝑤𝑖𝑘 ∗ 𝑤𝑗𝑘 ∗ 𝐶𝑖,𝑗) (𝑗 ≠ 𝑖)
4
𝑗=1
4
𝑖=1  
 
 
Where wik is the square root of the sample size times the heritability for trait i, Zik is the test statistic of 
SNP k in the GWAMA of trait i, Vik is the variance of the test statistic for SNP k in the GWAMA of trait i 
(i.e 1 given that Z is a standardized test statistic), and Ci,j,k is the covariance between (standardized) test 
statistics for SNP k between GWAMA of trait i and trait j (where C equals CTI obtained from cross trait 
LD score regression between trait i and trait j, and V is the univariate LD score intercept). Under the null 
hypothesis (no heritability) the test statistics have unit variance and the covariance Ci,j, is equal to a 
correlation. The multivariate test statistic Ζ𝑘, is a weighted sum of tests statistics all of which follow a 
normal distribution under their respective null distributions. The statistic Ζ𝑘 follows a standard normal 
distribution under the null hypothesis of no effect. 
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Model averaging GWAMA (MA-GWAMA) 
Consider the following model: 
 
𝛽 = 𝑀𝑉𝑁(𝛾𝑋 + 𝑒, 𝑉) 
 
Where 𝛽 (1xn) is a multivariate normal vector of effect sizes obtained from the regression of n 
standardized traits on a standardized genotype (SNP). The matrix V (nxn) is the variance-covariance 
matrix of effect sizes, matrix X a design matrix (pxn), and 𝛾 the corresponding vector of parameters (1xp). 
The indexed p denotes the number of variables included in the means model of the response vector 𝛽, and 
e is the error term. 
In this context, a regular GWAMA restricts the design matrix X to a unit vector (i.e. we model a single 
genetic effect, which is assumed identical across cohorts, and any observed variation is attributed to 
sample fluctuation). Generally, matrix V is diagonal and contains the squared standard errors of elements 
in 𝛽. A regular GWAMA is the most restricted model one can consider. However, when considering 
multivariate GWAMA (i.e. the elements in β reflect SNP effects on separate yet correlated traits), this 
model might be too restrictive. Even when traits have a substantial genetic correlation, not all genetic 
effects need to be shared between traits or be identical in magnitude. The least restrictive model is to 
consider the SNP effects in 𝛽 independent (i.e. run univariate GWAMA of the correlated traits). In 
between the most restrictive and least restrictive model, a manifold of models can be specified, equating 
the effects in 𝛾 across combinations of traits, while allowing it to differ between other combinations of 
traits. These models can be specified by ways of the design matrix X.  
One could consider a manifold (z) of models (m), each with a different design matrix X. 
 
𝛽1 = 𝑀𝑉𝑁(𝛾1𝑋1 + 𝑒, 𝑉) 
𝛽2 = 𝑀𝑉𝑁(𝛾2𝑋2 + 𝑒, 𝑉) 
𝛽𝑧 = 𝑀𝑉𝑁(𝛾𝑧𝑋𝑧 + 𝑒, 𝑉) 
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When considering i correlated traits, a simple expansion of X is to allow for 2 vectors (p =2), a unit vector 
and a second vector which is coded dichotomously (0,1), where the coding varies over each of the z 
models. Other codings, based on analysis of the genetic correlation between traits (i.e. PCA or Cholesky 
decomposition), can be applied to summary statistics and included in the average. Practically, this allows 
for the existence of 2 distinct genetic effect. This procedure results in . 5 ∗ 𝑝2 models. The 1-df model with 
a unit vector for X and (.5 ∗ 𝑝2 −  1) 2-df models with a unit vector and a second vector which codes for 
all possible combinations of pairs of k traits. However, simply considering m models for all SNPs across 
the genome results in a prohibitive increase of the already substantial multiple testing burden. Given z 
possible models, each of which predict a different vector 𝛾, and uncertainty for the predicted elements in 
𝛾, a possible way forward is to average the model predictions. The models are weighted by the relative 
proportion of evidence for each model. Specifically, the weights can be based on the AICc41 information 
criteria. The AICc for model m equals: 
 
𝐴𝐼𝐶𝑐𝑚 =  − ln(𝐿𝑜𝑔𝐿𝑖𝑘𝑚) +  2𝑘𝑚 + 
2𝑝𝑚(𝑝𝑚 + 1)
𝑧 − 𝑝𝑚 − 1
 
 
For each AICc we compute the delta (Δm) to the best (i.e lowest) AICc value, and from these we compute 
the model weights (g) for the p models as: 
 
𝑔𝑚 =
exp (− 
1
2 Δm)
∑ exp (− 
1
2 Δm)
𝑧
𝑚=1
  
 
We predict the vector β using each of the models 
?̂?𝑚 =  𝛾𝑚𝑋𝑚  
 
One can aggregate the prediction over all models as:  
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𝛽𝑎 =  ∑
?̂?𝑚 ∗ 𝑔𝑚
∑ 𝑔𝑚
𝑧
𝑚=1
𝑧
𝑚=1
 
 
And we aggregate the uncertainty within and between models to obtain 𝑣𝑎𝑟 (𝛽𝑎): 
𝑣𝑎𝑟(𝛽𝑎) =  [ ∑ gm√var(?̂?𝑚) +  (?̂?𝑚 −  ?̂̅?)2
z
m=1
]
2
 
 
The resulting vector 𝛽𝑎contains the model averaged effect sizes for the effect of a particular SNP on the 
traits subjected to multivariate analysis. Note how the variance estimate contains a variance component 
which reflects within model variability (var(?̂?𝑚)) which equals the square of the standard error, and a 
variance component between model variability ((?̂?𝑚 −  ?̂̅?)
2) in estimate, which ensures no overfitting 
occurs.  
Our procedure boosts power if the SNP effect is concordant between traits, while retaining strongly 
discordant SNP effects if the model favors these. Model averaging offers several avenues for extension. 
One can constrain the SNP effects across multiple SNPs based on biological knowledge of the relation 
between the SNPs and gene expression, or CpG methylation (analog to TWAS). Alternatively, it might be 
beneficial to average the AICc weights across regions of the genome. Model averaging can in principle 
accommodate any model for which the AICc information criterion can be expressed. These models should 
result in a vector of SNP effects (𝛽) and an asymptotic variance for the SNP effects. In the current 
application, models per SNP are estimated in R using the “metafor” package and models are averaged 
using the “AICcmodavg” package42,43.  
Simulations 
We performed simulations to elucidate in which scenarios N-GWAMA and MA-GWAMA outperform 
univariate GWAMA, and when N-GWAMA outperforms MA-GWAMA, or the reverse. For each scenario 
we simulated four heritable traits (hSNP
2 = 30%) effected by 80K SNPS. The genetic correlation between 
the four traits varied between .1 and .9. Using real genotypes and simulated effects,  
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We sampled 80,000 causal SNPs for 80,000 individuals from the UK Biobank12. For each trait, 40,000 
individuals were simulated, in which the sample overlap between the traits ranged from 0 to 25,000 
individuals to conducts univariate GWAMA including 656,284 genotyped SNPs (MAF > 0.01). This 
introduced partial sample overlap between the univariate GWAMA. Next, we performed N-GWAMA and 
MA-GWAMA analyses and correlated the true SNP effects with the estimated SNP effects obtained from 
the univariate GWAMA, N-GWAMA, and MA-GWAMA. 
We performed another four simulation scenarios in which we varied the SNP heritability together with the 
sample size. We kept the product of the h2SNP and the sample size constant in order to test whether at lower 
h2SNP and higher sample size (more in line with our empirical application) our findings concerning the 
relative power of univariate GWAMA, N-GWAMA, and MA-GWAMA persist. The constant product of N 
X h2SNP implies that the expectation of the squared z-statistic remains constant according to the 
expectation of the square Z statistics as formulated in Bulik-Sullivan et al.2015: (see online methods) 
𝐸[𝜒2|ℓ𝑗] =
𝑁ℎ2
𝑀
ℓ𝑗 + 𝑁𝑎 + 1 
To validate MA-GWAMA, we simulated data where the assumption of a unitary effect of the SNP on all 
traits was relaxed. We again simulated four traits, which were affected by 80K SNPs. The SNP effects are 
perfectly correlated, however, we replaced true effects with zero in a way that guarantees that 10K SNPs 
have a true effect on only one trait, 10K SNPs have a true effect on two traits, and 10K SNPs have a true 
effect on three traits. Based on these effect sizes and genotypes we simulated traits for 100K individuals 
and performed univariate GWAMA, N-GWAMA, and MA-GWAMA analyses as described above.  
Polygenic Prediction 
To confirm the gain in power of our multivariate approaches, we performed polygenic score prediction 
(PRS) in two independent samples; 1) the Netherlands Twin Register (NTR)2323,44 and 2) Understanding 
Society (UKHLS)17. We predicted the traits in the well-being spectrum (life satisfaction, positive affect, 
neuroticism, and depressive symptoms). In NTR, LS and PA data were available in 9,143 and 6,836 
genotyped participants, respectively. LS was measured longitudinally using the 5-item Satisfaction with 
Life Scale45. PA is also measured longitudinally using four questions that were adapted from the 
Subjective Happiness Scale46. Neuroticism data were available for 8,527 genotyped participants. The Big 
Five personality traits (including neuroticism) were measured by using the NEO-FFI47, a personality 
questionnaire consisting of five subscales: neuroticism, extraversion, openness, agreeableness and 
conscientiousness. Depressive symptoms were obtained from the DSM-oriented Depression subscale of 
the age-appropriate survey from the ASEBA taxonomy48 and were available for 7,898 participants.  
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In UKHLS data were available for 9,944 participants. LS was measured longitudinally (waves 1-6). 
Participants were asked how satisfied they were “with life overall”, with responses given on a seven-point 
scale. PA was also measured longitudinally (waves 1 and 4 only) using The Warwick-Edinburgh Mental 
well-being scale (SWEMWBS)49, which is a shortened version of WEMWBS. Neuroticism data were 
available for 8,198 genotyped participants from wave 3. The Big Five personality traits (including 
neuroticism) were measured using The Big Five Inventory (BFI), a personality questionnaire consisting of 
five subscales: neuroticism, extraversion, openness, agreeableness and conscientiousness. Depressive 
symptoms (DS) were measured longitudinally (waves 1-6) and was obtained from The General Health 
Questionnaire (GHQ), which was available for 9,203 participants.  
The weights used for the polygenic scores were based on the four univariate GWAMAs as well as our two 
flavors of multivariate GWAMAs. Scores were based on the intersection of SNPs available in any of these 
GWAMAs and the prediction sample. Both in NTR and UKHLS, SNPs were imputed to 1000 Genomes 
project March 2012 version 350. In NTR, 1,224,793 SNPs and in UKHLS, 955,441 SNPs passed QC, 
respectively, and were used to construct polygenic scores. The traits were regressed on sex and age as well 
as principal components included to correct for ancestry, and the polygenic scores. Results can be found in 
Supplemental Table 12. 
Summary-Based transcriptome wide (TWAS) association studies 
Gene expression exhibits strong allelic heterogeneity51, where multiple SNPs local to the gene jointly 
influence gene expression levels. We aggregated SNP effects informed by their common effect on 
expression level of gene (TWAS) or CpG methylation (MWAS), as proposed by Gusev et al.26. For TWAS 
we used the RNA-seq data from the BIOS Consortium52. The BIOS Consortium provides a data 
infrastructure hosting genetic (imputed SNPs), methylome (Illumina 450k array), transcriptome (RNA-
seq), and phenotypic data on ~4000 individuals from 6 Dutch biobanks, and a catalog with research output 
(see URLs). We used 3,344 whole blood RNA-seq samples, measured with Illumina’s Hiseq2000 (Paired-
end sequencing of 2x50bp, >15M read pairs per sample). Batch effects and the first 50 PC's without a 
GWAS hit were removed from the RNA-seq data, which was quantile-normal normalized for each gene. 
The corresponding genotype data we used consisted of 881,977 unambiguous HapMap SNPs (MAF>5%, 
minor allele count > 10, imputation info score > 0.8). For eQTL analysis, linear regression on each SNP-
gene pair closer than 250k bp was performed. FDR was based on 10 permutations: subject labels were 
permuted and eQTL analysis was repeated, subsequently top associations per gene were counted and 
compared between permuted and observed data53. At FDR 5% (p < 1e-5) there were 13,870 genes with a 
significant eQTL. For each gene with a significant eQTL, a lasso model was fit in R with the function 
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glmnet, with all SNPs closer than 250k bp to the gene as predictors, and gene expression as outcome. For 
each gene, Lasso reduces the predictors to an optimal amount and provides the prediction model of gene 
expression (E) based on local SNPs S1- SN and lasso weights q=q1,q2,...,qn,: 
𝐸 = ∑ 𝑞𝑖𝑆𝑖
𝑛
𝑖=1
 
Based on the prediction models, N-GWAMA summary statistics and LD based on the 1000 Genomes 
reference, TWAS was performed. That is, for each gene- prediction-model containing SNPs S1- SN with 
weights q=q1,q2,...,qn, the corresponding GWAMA z-scores z=z1,z2,...,zn and LD, an n-by-n correlation 
matrix for eQTLs S1- SN, were used to construct the TWAS test statistic for each gene: 
 
𝑍𝑡𝑤𝑎𝑠 =
∑ 𝑞𝑖𝑧𝑖
𝑛
𝑖=1
√𝑞 ∗ 𝐿𝐷 ∗ 𝑞 
 
TWAS prediction models and LD matrices can be downloaded , and can be used to test for association 
between the estimated cis (DNA) component of gene expression and the phenotype used for GWAS (see 
URLs). 
Summary-Based methylome wide (MWAS) association studies 
By applying the same approach as TWAS, MWAS was performed using prediction models for each DNA 
methylation CpG, with local SNPs as predictors. We used whole blood methylation data from the BIOS 
Consortium54: 4,008 samples measured with Illumina 450K arrays. Methylation pre-processing was the 
same as for RNA. Genotype and mQTL analysis procedures were the same as for eQTL analysis. At FDR 
5% (P<9.3e-05) there were 151,729 CpG's with a significant mQTL. For each CpG with a significant 
mQTL we made a prediction model of methylation based on local SNPs (which is a weighted linear 
combination of SNPs). Based on the prediction models, MWAS statistics were generated (see the formula 
for TWAS). MWAS prediction models and corresponding LD matrices can be downloaded (see URLs).  
Stratified LD score regression 
To determine whether specific genomic regions are enriched for genetic effects on the well-being 
spectrum, we used LD Score regression2,3. We were specifically interested in regions of the genome that 
are histone modified in a specific tissue.  
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We followed the exact procedure described by Finucane et al.
28
, and estimated stratified LD Score 
regression for the “baseline” model, which contains 53 categories. In addition, we performed analyses 
using cell type-specific annotations for the four histone marks, corresponding to specific chemical 
modifications of the histone protein, which packages and orders the DNA molecule. Epigenetic 
modifications of histones, specifically histones bearing the marks H3K4me1, H3K4me3, H3K27ac or 
H3K9ac, are associated with increased transcription of DNA into RNA. Each cell type-specific annotation 
corresponds to a histone mark in a specific cell obtained from distinct human tissue, for example H3K27ac 
in Fetal Brain cells, generating 220 combinations of histone modification by tissue. When generating 
estimates of enrichment for the 220 Histone marks by tissue annotations, we controlled for overlap with 
the functional categories in the full baseline model, but not for overlap with the 219 other cell type 
specific annotations. For the well-being spectrum, we ran LD Score regression on each of the 220 models 
(one for each histone by tissue combination) and ranked the histone by tissue annotations by P-value 
derived from the Z-values of the coefficient. Results are displayed in Supplementary Table 15. 
Stratified LD score regression of local gene expression across the human brain. 
We downloaded the normalized and QC’ed gene expression measured in an anatomically comprehensive 
set of brain regions (see URLs). The data contain 3707 measurements across 6 adult human brains (see 
Hawrylycz et al29). We computed differential gene expression for 48154 probes which map to 20724 
unique genes (probes which did not map to genes were omitted). We considered differential gene 
expression across 210 regions for which at least 3 measurements were available. As Hawrylycz et al.29  
found little evidence for lateral difference in gene expression, regions in the left and right hemisphere 
were collapsed into a single region. For each gene in each region a t-test was performed, testing the 
difference in standardized expression between the region in question and all other brain regions. The top 
10% of probes ranked in terms of t-statistic per region were retained. The unique genes mapped to this set 
of probes were extracted (mapping ~2900-3500 genes to each region). The correlation between t-statistics 
for the 48,154 probes revealed fairly strong differential expression between the cortex, brainstem, and 
cerebellum and clustering of differential expression within these regions. 
A partitioned LD score with respect to the genomic regions spanned by these genes (using gencode v19 as 
a reference), and a 100 kb window around each gene, was computed. The heritability of well-being was 
partitioned across the 54 baseline annotations28 and each of the 210 brain regions (the regions are 
considered separately). The substantial differences in gene expression between gross anatomical brain 
regions (cerebellum, cortex, sub-cortical regions and brainstem) dominated the results (Supplementary 
Table 16). We therefore proceeded to compute differential gene expression within the cerebellum, cortex, 
sub cortical regions, and brainstem. In this analysis we omitted the fibre bundles as these are anatomically 
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distinct from both the cortex and the sub cortical regions, yet not measured densely enough to warrant the 
computation of differential expression within these fibre bundle tissues. The procedure to compute 
differentially expressed genes is identical to the procedure used to compute differential expression across 
the whole brain, but considers the gross anatomical regions separately. New LD scores were computed 
based on the local differential gene expression analyses (Supplementary Table 17-20). All analyses were 
repeated using height as a negative control trait. The genomic regions spanning genes differentially 
expressed in these 210 brain regions were not significantly enriched with SNP effects on height.  
Stratified LD score regression of Single nuclei for 7 types of neurons 
We obtained the publicly available matrix of gene counts generated based on single nuclei from the 
prefrontal cortex and hippocampus of multiple human donors by Habib et al (2017)34. To compute 
differential enrichment we deviated from the procedure outlined for regional brain expression as the zero 
inflated nature of single nuclei expression violates assumptions of the t-test. The matrix contained counts 
for 32111 genes measured in 14964 nuclei. The nuclei were divided into 7 types of neurons, 2 subtypes of 
astrocytes, oligodendrocytes, oligodendrocyte precursors cells, microglia, endothelial cells, and 
unclassified cells. We omitted genes for which the total count across cells < 150, or for which less than 30 
cells have a count above 0, retaining 11719 genes for analysis. For each gene we computed the ratio of 
count per nuclei type over the total number of nuclei measured of the specific type (generating the average 
gene count in each nuclei type). Next, we computed the ratio of the average count per nuclei type over the 
average count of the gene across all nuclei (generating the nucleic type specific fold change in average 
expression). We then defined, for each nuclei type, the nuclei type specifically expressed set of genes as 
the 1600 genes with the highest nucleic type specific fold change in average expression. For each of the 
gene sets we constructed an LD score with respect to genes in the set, in order to compute the gene set 
specific enrichment in h2 in our multivariate GWAMA. 
Our method to determine cell-type specific expression purely relies on the relative (standardized) 
expression in one cell type over the (standardized) expression in others, whereas others have developed 
perhaps more sophisticated statistics to assess differential expression55. The test statistics developed by 
Finucane et al. have never been applied to single cell data, which has a skewed distribution of counts, and 
we therefore used a simpler metric. Application of both methods to the same gene expression dataset 
(GTEX) and subsequent differential enrichment analysis for well-being yielded highly correlated 
enrichment estimates (r=.83).  
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Data Availability 
Summary Statistics excluding results from 23AndMe can be downloaded from 
https://surfdrive.surf.nl/files/index.php/s/Ow1qCDpFT421ZOO. The data transfer agreement with 
23AnMe stipulates that we can publish effect sizes associated with 10,000 SNPs. These summary statistics 
can be downloaded from https://surfdrive.surf.nl/files/index.php/s/Ow1qCDpFT421ZOO. For 23AndMe 
dataset access see:  https://research.23andme.com/dataset-access/ 
Life Sciences Reporting 
Further information on experimental design is available in the Life Science Reporting Summary 
Code availability 
N-GWAMA and MA-GWAMA software is available at: https://github.com/ 
baselmans/multivariate_GWAMA/ 
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